Atypical immunologic response in a patient with CRIM-negative Pompe disease
- 11 August 2011
- journal article
- case report
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 104 (4), 583-586
- https://doi.org/10.1016/j.ymgme.2011.08.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CRIM‐negative infantile Pompe disease: 42‐month treatment outcomeJournal of Inherited Metabolic Disease, 2010
- Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe diseaseGenetics in Medicine, 2008
- Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis IJCI Insight, 2008
- Recombinant human acid α-glucosidaseNeurology, 2007
- Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- Efficacy of an Adeno-associated Virus 8-Pseudotyped Vector in Glycogen Storage Disease Type IIMolecular Therapy, 2005
- The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the LiteraturePediatrics, 2003
- Immune Response to Enzyme Replacement Therapy in Lysosomal Storage Disorder Patients and Animal ModelsMolecular Genetics and Metabolism, 1999
- Left ventricular myocardial mass determined by cross-sectional echocardiography in normal newborns, infants, and childrenPediatric Cardiology, 1991